Ross N. England, MD, PhD
Locations: Main Building
About Ross N. England, MD, PhD
Titles
Attending Physician, Division of Infectious Diseases
Certifications
Internal Medicine – American Board of Internal Medicine
Pediatrics – American Board of Pediatrics
Awards and Honors
2015, Angelo DiGeorge Prize for Excellence in Pediatrics
2015, Charles H. Kravitz, M.D. Award in Internal Medicine
2015, Carson Schneck, M.D., Ph.D. Scholarship
2011, Graduate Student Research in Pathology Award
2008, Evan Pugh Senior Scholar Award
2007, Undergraduate Summer Discovery Grant
2007, Evan Pugh Junior Scholar Award
2005, President's Freshman Award
2004-2008, Schreyer Honors College Academic Excellence Award
2004-2008, Dean's List - The Pennsylvania State University
Leadership and Memberships
Phi Beta Kappa Society
Alpha Omega Alpha Honor Medical Society (AOA)
American College of Physicians (ACP)
American Academy of Pediatrics (AAP)
Infectious Diseases Society of America (IDSA)
Pediatric Infectious Diseases Society (PIDS)
Education & training
Medical Degree
MD - Lewis Katz School of Medicine at Temple University, Philadelphia, PA
PhD - Molecular and Cellular Physiology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
Residency
Combined Internal Medicine and Pediatrics, Harvard/Brigham and Women's Hospital/Boston Children's Hospital, Boston, MA
Fellowship
Combined Adult and Pediatric Infectious Diseases, University of Pennsylvania Health System/Children's Hospital of Philadelphia, Philadelphia, PA
Publications
Publications
2020
Kulick-Soper CV, McKee JL, Wolf RL, Mohan S, Stein JM, Masur, JH, Lazor JW, Dunlap DG, McGinniss JE, David MZ, England RN, Rothstein A, Gelfand MA, Cucchiara BL, Davis KA. Pearls and Oy-sters: Bilateral globus pallidus lesions in a patient with COVID-19. Neurology 2020; 95(10): 454-57.
England RN, Pak J, Liu M, Rao S, Azono O, Levy O, van Haren SD. The Distinct Neonatal Immune Response to Toll-like Receptor 7/8 Activation is Controlled by Plasma Factors Through the Expression of Let-7g. In Submission
2017
Gabunia K, Herman AB, Ray M, Kelemen SE, England RN, DeLa Cadena R, Foster WJ, Elliott KJ, Eguchi S, Autieri MV. Induction of MiR133a Expression by IL-19 Targets LDLRAP1 and Reduces oxLDL Uptake in VSMC. J Mol Cell Cardiol 2017; 105: 38-48.
2014
Kako F, Gabunia K, Ray M, Kelemen SE, England RN, Kako B, Scalia RG, Autieri MV. Interleukin-19 Induces Angiogenesis in the Absence of Hypoxia by Direct and Indirect Immune Mechanisms. Am J Physiol Cell Physiol 2016; 310(11): C931-41. 2014
Ellison S, Gabunia K, Richards JM, Kelemen SE, England RN, Rudic D, Azuma YT, Munroy MA, Eguchi S, Autieri MV. IL-19 Reduces Ligation-Mediated Neointimal Hyperplasia by Reducing Vascular Smooth Muscle Cell Activation. Am J Pathol 2014; 184(7): 2134-43.
2013
Ellison S, Gabunia K, Kelemen SE, England RN, Scalia R, Richards JM, Orr AW, Traylor JG Jr, Rogers T, Cornwell W, Berglund LM, Goncalves I, Gomez MF, Autieri MV. Attenuation of Experimental Atherosclerosis by Interleukin-19. Arteriorscler Thromb Vasc Biol 2013; 33(10): 2316-2324.
England RN, Preston KJ, Scalia R, Autieri MV. Interleukin-19 Decreases Leukocyte-Endothelial Cell Interactions by Reduction in Endothelial Cell Adhesion Molecule mRNA Stability. Am J Physiol Cell Physiol 2013; 305(3): C255-65.
2012
Sommerville LJ, Kelemen SE, Ellison SP, England RN, Autieri MV. Increased atherosclero- sis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet. Atherosclerosis 2012; 220(1): 45-52. England RN, Autieri MV. Anti-in ammatory e ects of interleukin-19 in vascular disease. Int J In amm 2012; 253583.
2011
Gabunia K, Jain S, England RN, Autieri MV. Anti-in ammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility. Am J Physiol Cell Physiol 2011; 300(4): C896-906.